AJOG MFM/LinkedIn
Dec 26, 2025, 13:09
Postpartum Readmission Rates Linked to Antihypertensive Choice – AJOG MFM
American Journal of Obstetrics and Gynecology MFM – AJOG MFM shared a post on LinkedIn:
“In a retrospective cohort of individuals with hypertensive disorders of pregnancy, discharge with labetalol rather than nifedipine was independently associated with increased risk of postpartum hospital readmission (9.2% vs 3.9%, P<.001).
Read the full text here.”
Title: Postpartum health-care utilization and blood pressure control by antihypertensive agent in hypertensive disorders of pregnancy
Authors: Carrie Bennett, Lara Lemon, Kripa Venkatakrishnan, Sanjana Ghosh, Hyagriv Simhan, Alisse Hauspurg
Stay updated on all scientific advances in the field of fertility with Fertility News.
-
Oct 11, 2025, 06:44The Global IVF Market Is Set to Reach $65B by 2032 – Meddilink
-
Jan 10, 2026, 06:50Owen Xian Wen Tan: New Insights on β2-Glycoprotein I in Thrombosis Regulation
-
Jan 10, 2026, 06:35John Cush: Assess Reproductive Health in SLE Clinic Visits
-
Jan 10, 2026, 06:25Explore Key Topics in Rheumatology at RheumReview 2026 – Canadian Rheumatology Association
-
Jan 10, 2026, 06:09Insights on Molecular Heterogeneity in Endometriosis Treatment – HER Heard
-
Jan 10, 2026, 06:07Exploring Gut Health’s Role in Endometriosis Management – Womb WatchAI
-
Jan 10, 2026, 05:33Yasmin Magdi: Critical Concerns In POSTAL Study on Thyroid and IVF
-
Jan 10, 2026, 03:00Naila Jabeen: Understanding Genetic Factors in IVF Success
-
Jan 9, 2026, 11:20Lucile Ferreux: What History Teaches Us About the Place of Human Health
-
Jan 9, 2026, 11:02January Insights Reflecting on 2025’s Top Fertility Research – RBMO